U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511010) titled 'Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets' on March 20.
Brief Summary: This trial includes two parts: a food effect (FE) study and a multiple-dose pharmacokinetic (PK) study.
The FE study is a randomized, open-label, two-period, two-sequence crossover study designed to evaluate the effect of a high-fat meal on the PK of a single oral dose of Chiglitazar/Metformin extended-release tablets in healthy adult Chinese participants.
The multiple-dose PK study is an open-label study designed to evaluate the PK characteristics of Chiglitazar/Metformin extended-release tablets in healthy adult Chi...